2018
DOI: 10.1016/j.jse.2017.12.033
|View full text |Cite
|
Sign up to set email alerts
|

The management of infected elbow arthroplasty by two-stage revision

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
26
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 21 publications
2
26
0
2
Order By: Relevance
“…of participantsNo. of elbows jointsQuality scoreOne-stage Gille, 2006 [23]Germany1978–199962.70.0RA (100%)NA S. aureus Flucloxacillin6.81015610 Spormann, 2012 [24]Switzerland1994–2007*67.00.0NRNA CNSA Oral ciprofloxacin/rifampin given4.00NRNR1111Two-stage Yamaguchi, 1998 [12]USA1981–199453.840.0RA (80%); OA (20%)3.7 S. aureus; S. epidermidis None given4.11015511 Yamaguchi, 1999 [22]USA1981–199459.728.6RA (85.7%); PTA (14.3%)NR S. aureus; S. epidermidis NR4.31047710 Achermann, 2011 [13]Switzerland1994–2007NRNRRA; OA5.5NRFlucloxacillin/rifampinNR0NRNR229 Spormann, 2012 [24]Switzerland1994–200754.5100RA; PTA; OA; psoriasisNR CNSA Flucloxacillin/rifampin6.40NRNR4411 Peach, 2013 [25]UK1998–201065.030.3RA; fracture; OA; PTA9.0 CNSA Cefuroxime4.3402333411 Rudge, 2018 [26]UK2009–201464.731.6RA; PTA; fracture; OA6....…”
Section: Resultsmentioning
confidence: 99%
“…of participantsNo. of elbows jointsQuality scoreOne-stage Gille, 2006 [23]Germany1978–199962.70.0RA (100%)NA S. aureus Flucloxacillin6.81015610 Spormann, 2012 [24]Switzerland1994–2007*67.00.0NRNA CNSA Oral ciprofloxacin/rifampin given4.00NRNR1111Two-stage Yamaguchi, 1998 [12]USA1981–199453.840.0RA (80%); OA (20%)3.7 S. aureus; S. epidermidis None given4.11015511 Yamaguchi, 1999 [22]USA1981–199459.728.6RA (85.7%); PTA (14.3%)NR S. aureus; S. epidermidis NR4.31047710 Achermann, 2011 [13]Switzerland1994–2007NRNRRA; OA5.5NRFlucloxacillin/rifampinNR0NRNR229 Spormann, 2012 [24]Switzerland1994–200754.5100RA; PTA; OA; psoriasisNR CNSA Flucloxacillin/rifampin6.40NRNR4411 Peach, 2013 [25]UK1998–201065.030.3RA; fracture; OA; PTA9.0 CNSA Cefuroxime4.3402333411 Rudge, 2018 [26]UK2009–201464.731.6RA; PTA; fracture; OA6....…”
Section: Resultsmentioning
confidence: 99%
“…Guidelines on treatment options such as removal versus retention of the implant in case of periprosthetic infection of the elbow have been written by Morrey et al 15 Most knowledge on periprosthetic elbow infections is from TEA. 63 The guidelines on possible implant retention will also apply to RHA, with the advantage of RHA being that removal of the prosthesis will be better tolerated.…”
Section: Diagnosis and Treatmentmentioning
confidence: 99%
“…Although a consensus is not fully established, two-stage revision surgery is commonly recommended. [79][80][81] Zmistowski et al 82) reported that two-stage revision led to a decreased rate of recurrent PJI and a 50% success rate over 3 years, and they recommended a prosthesis-free interval of at least 3 months. The most common pathogen was Staphylococcus aureus.…”
Section: Periprosthetic Joint Infectionmentioning
confidence: 99%